BioSpace News Archive

Advicenne today announced that the management of Advicenne will host a conference call on Wednesday September 12, 2018 at 6:00 pm (CEST) to comment on the latest positive developments of its product portfolio.

Eyevance Pharmaceuticals, LLC, a Fort Worth-based pharmaceutical company committed to developing and commercializing innovative and impactful ophthalmic products, today announced the acquisition of FRESHKOTE® - a family of lubricant eye drops from Focus Laboratories, Inc.

Concordia International Corp. today announced that as part of the Company’s recently completed and previously announced recapitalization transaction (the “Recapitalization Transaction”), the Company completed on September 6, 2018, a US$586.5 million private placement for new equity at a price of US$13.69 per limited voting share,

21Medtech announced that Professor Matthew Becker, 21Medtech founder and inventor, has become the 20th recipient of the Carl S. Marvel Award in Creative Polymer Chemistry recognizing his accomplishments of unusual merit in the field of applied polymer science.

Synvitrobio, the leader in cell-free natural product discovery, announced the closure of an oversubscribed $2.6 million seed funding round, led by Social Capital, with participation from Fifty Years and KdT Ventures.

MabVax Therapeutics Holdings, Inc. (OTC: MBVX), a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the development of antibody-based products to address unmet medical needs, announced today that the Company has filed, in the Superior Court of California, County of San Diego, a complaint against a law firm that previously represented the Company in certain corporate, securities, and Securities and Exchange Commission (“SEC”) matters.

DATATRAK International, Inc. (OTCQX: DTRK), a software-as-a-service provider and innovation leader of cloud-based technologies for the life sciences industry, today announced it will be Sponsoring the Association of Clinical Research Professionals (ACRP) Greater San Diego Chapter’s Symposium in San Diego California, September 14, 2018.

Pet health, vet health; WellHaven was founded on the principle that you can’t have one without the other. A new partnership with CUBEX--the industry leader in inventory management solutions--elevates WellHaven Pet Health hospital operating efficiency, increases practice safety, helps teams succeed, and ultimately, improves quality of life for pets and veterinarians.

This replaces the announcement made at 06:45 pm CEST on 09/11/2018 due to the following corrections: correction in the title.

Regen BioPharma Inc. has identified a series of small molecule drugs that inhibit NR2F6.